C1q inhibits autoantibody binding to calreticulin

Abstract

Calreticulin (CR) is a new rheumatic disease-associated autoantigen that is intimately associated with the Ro/SS-A ribonucleoprotein. CR autoantibodies are frequently observed in patients with photosensitive forms of lupus erythematosus (LE). CR has been shown to be highly homologous to cC1q-R, the cell surface receptor that binds the collagenous domain of the first component of complement, C1q. C1q has also been shown to directly bind to CR. We therefore asked whether the binding of C1q to CR might interfere with the binding of CR autoantibody to CR. Full-length recombinant human CR, an E.coli fusion proteins was used as antigen in a direct enzyme-linked immunosorbent assay (ELISA). CR autoantibody-containing sera were assayed before and after C1q removal by two different methods: by heating sera at 56C for 30 min or adding monoclonal anti-C1q antibodies. ELISA optical density (OD) values were found to be consistently higher in sera depleted of C1q by both methods compared to unmodified sera. The addition of purified C1q to C1q-depleted sera resulted in ELISA OD values similar to those of unmodified sera. These results suggest that C1q levels present in human serum can inhibit the binding of CR autoantibody to CR. One can speculate that the failure of C1q to mask CR autoepitopes in individuals with genetic deficiency of C1q could contribute to the high rate of photosensitive LE that occurs in such individuals.

Keywords

C1q autoantibodies calreticulin LE photosensitivity

Get full access to this article

View all access options for this article.

References

Sontheimer RD , Lieu T-S , Capra JD. The diverse functional repertoire of calreticulin, a new human autoantigen . The Immunologist 1993; 1: 155 – 160

Sontheimer RD , Nguyen TQ , Cheng ST et al. The unveiling of calreticulin – A clinically relevant tour of modern cell biology . I Invest Med. 1995; 43: 362 – 370 .

Sontheimer RD et al. Calreticulin and autoimmunity In: Calreticulin. Michalak M . (ed.) R.G. Landers Co., Biomedical Publishers, Austin , 1996; pp 117 – 139.

Eggleton P , Reid KBM , Kishore U , Sontheimer RD. Clinical relevance of calreticulin in systemic lupus erythematosus . Lupus 1997; 6: 564 – 571 .

Michalak M , Milner RE , Burns K , Opas M. Calreticulin Biochem J. 1992; 285: 681 – 692 .

Helenius A , Trombetta ES , Hebert DN , Simons JF. Calnexin, calreticulin, and the folding of glycoproteins Trend . Cell. Biol. 1997; 7: 193 – 200 .

Cheng ST , Nguyen TQ , Yang YS et al. Calreticulin hinds hYRNA and the 52 KD polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen . J. Immunol. 1996; 156: 4484 – 4491 .

Lieu TS , Sontheimer RD . A subpopulation of Wil-2 Cell calreticulin molecules is associated with Ro/SS-A ribonucleoprotein particles . Lupus 1997; 6: 5640 – 5647 .

Schofield RH , Racila DM , Kurien BT , Sontheimer RD . Anti-calreticulin segregates anti-Ro sera in systemic lupus erythematosus; anti-calreticulin is present in sera with anti-Ro alone but not in anti-Ro sera with anti-La or anti-RNP J. Rheumatol 1999; accepted for publication

10.

Eggleton P , Lieu TS , Zappi EZ et al. Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein . Clin. Immunol. Immunopathol. 1994; 72: 405 – 409 .

11.

Malhotra R , Willis AC , Jensenius JC et al. Structure and homology of the human C1q receptor (collectin receptor) . Immunology 1993; 78: 341 – 348

12.

Kishore U , Sontheimer RD , Sastry KN et al. Release of calreticulin from neutrophils may alter C1q-mediated immune functions . Biochem. J. 1997; 322: 543 – 550 .

13.

Kishore U , Sontheimer RD , Sastry KN et al. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1qassociation with immune complexes . Clin. Exp. Immunol. 1997; 108: 181 – 190

14.

Lieu T-S , Newkirk M , Capra JD , Sontheimer RD . Molecular characterization of human Ro/SS-A antigen: amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity to a corresponding synthetic peptide . J. Clin. Invest. 1988; 82: 96 – 101

15.

Lieu T-S , McCauliffe DP , Newkirk MM et al. A major autoepitope is present on the amino terminus of the human Ro/SS-A polypeptide . J. Autoimmunity 1989; 2: 367 – 374

16.

Stuart GR , Lynch NJ , Day AJ et al. The C1q and collectin binding site within C1q receptor (cell surface calreticulin) . Immunopharmacology 1997; 38: 73–80

17.

Korb LC , Ahearn JM . C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes<Eth>complement deficiency and systemic lupus erythematosus revisited . J. Immunol. 1997; 158: 4525 – 4528